Insider Trading activities at Nuvectis Pharma, Inc. (NVCT)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Nuvectis Pharma, Inc. (NVCT) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Nuvectis Pharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1875558.

Total stock buying since 2022: $8,175,881.
Total stock sales since 2022: $22,478.
Total stock option exercises since 2022: $0.


7 insiders reported insider trading activities at Nuvectis Pharma, Inc. (NVCT):
Insider trading activities of Shemesh Shay
Insider trading activities of Carson Michael J.
Insider trading activities of Hoberman Kenneth
Insider trading activities of Kaplan Matthew L.
Insider trading activities of Bentsur Ron
Insider trading activities of Mosseri Marlio Charles
Insider trading activities of Poradosu Enrique

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Nuvectis Pharma, Inc. (NVCT).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 327,623 $1,919,846 0 $0 0 $0
2024 49,553 $275,783 2,755 $22,478 0 $0
2023 228,439 $3,735,925 0 $0 0 $0
2022 351,796 $2,244,327 0 $0 0 $0

Table 2. Monthly summary of insider trading at Nuvectis Pharma, Inc. (NVCT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-06 39,045 $314,298 0 $0 0 $0
2025-05 48,578 $405,548 0 $0 0 $0
2025-02 240,000 $1,200,000 0 $0 0 $0
2024-12 17,000 $79,900 0 $0 0 $0
2024-11 22,000 $108,380 2,755 $22,478 0 $0
2024-05 5,553 $36,054 0 $0 0 $0
2024-03 5,000 $51,449 0 $0 0 $0
2023-10 4,940 $54,650 0 $0 0 $0
2023-08 650 $9,528 0 $0 0 $0
2023-07 68,090 $1,004,760 0 $0 0 $0
2023-06 149,449 $2,602,304 0 $0 0 $0
2023-05 850 $14,647 0 $0 0 $0
2023-03 4,460 $50,036 0 $0 0 $0
2022-12 500 $3,825 0 $0 0 $0
2022-11 1,650 $12,021 0 $0 0 $0
2022-09 6,354 $50,652 0 $0 0 $0
2022-08 42,071 $359,425 0 $0 0 $0
2022-06 4,700 $55,002 0 $0 0 $0
2022-05 28,975 $488,633 0 $0 0 $0
2022-03 11,000 $81,610 0 $0 0 $0
2022-02 256,546 $1,193,159 0 $0 0 $0

Table 3. Detailed insider trading at Nuvectis Pharma, Inc. (NVCT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-06-20 Mosseri Marlio Charles Buy 5,603 7.99 44,767
2025-06-18 Mosseri Marlio Charles Buy 28,043 8.05 225,746
2025-06-17 Mosseri Marlio Charles Buy 5,399 8.11 43,785
2025-05-12 Mosseri Marlio Charles Buy 21,167 8.11 171,664
2025-05-08 Mosseri Marlio Charles Buy 2,650 8.65 22,922
2025-05-07 Mosseri Marlio Charles Buy 12,317 8.52 104,940
2025-05-06 Mosseri Marlio Charles Buy 12,444 8.52 106,022
2025-02-07 Mosseri Marlio Charles Buy 240,000 5.00 1,200,000
2024-12-13 Mosseri Marlio Charles Buy 17,000 4.70 79,900
2024-11-19 Poradosu Enrique (Chief Science & Business Officer) Buy 2,000 4.99 9,980
2024-11-15 Bentsur Ron (Chairman & CEO) Buy 20,000 4.92 98,400
2024-11-07 Carson Michael J. (Vice President, Finance) Sale 2,755 8.16 22,478
2024-05-14 Bentsur Ron (Chairman & CEO) Buy 1,940 6.74 13,075
2024-05-10 Poradosu Enrique (Chief Science & Business Officer) Buy 500 6.29 3,145
2024-05-10 Shemesh Shay (Chief Dev. & Ops. Officer) Buy 1,113 6.32 7,034
2024-05-10 Bentsur Ron (Chairman & CEO) Buy 2,000 6.40 12,800
2024-03-18 Bentsur Ron (Chairman & CEO) Buy 5,000 10.29 51,449
2023-10-10 Bentsur Ron (Chairman & CEO) Buy 640 11.08 7,091
2023-10-09 Bentsur Ron (Chairman & CEO) Buy 830 11.19 9,287
2023-10-06 Bentsur Ron (Chairman & CEO) Buy 250 11.27 2,817
2023-10-05 Bentsur Ron (Chairman & CEO) Buy 1,400 11.09 15,526
2023-10-04 Bentsur Ron (Chairman & CEO) Buy 1,820 10.95 19,929
2023-08-16 Bentsur Ron (Chairman & CEO) Buy 115 15.15 1,742
2023-08-15 Bentsur Ron (Chairman & CEO) Buy 235 14.34 3,369
2023-08-11 Bentsur Ron (Chairman & CEO) Buy 180 14.66 2,638
2023-08-08 Bentsur Ron (Chairman & CEO) Buy 120 14.83 1,779
2023-07-31 Mosseri Marlio Charles Buy 860 13.88 11,936
2023-07-28 Mosseri Marlio Charles Buy 2,584 13.91 35,943
2023-07-27 Mosseri Marlio Charles Buy 1,556 13.98 21,752
2023-07-26 Mosseri Marlio Charles Buy 10,000 13.97 139,700
2023-07-21 Mosseri Marlio Charles Buy 2,844 14.61 41,550
2023-07-21 Bentsur Ron (Chairman & CEO) Buy 225 14.85 3,341
2023-07-20 Mosseri Marlio Charles Buy 5,394 14.40 77,673
2023-07-20 Bentsur Ron (Chairman & CEO) Buy 110 15.06 1,656
2023-07-19 Mosseri Marlio Charles Buy 8,000 14.84 118,720
2023-07-19 Bentsur Ron (Chairman & CEO) Buy 200 14.33 2,866
2023-07-18 Mosseri Marlio Charles Buy 9,149 14.84 135,771
2023-07-14 Bentsur Ron (Chairman & CEO) Buy 150 15.03 2,254
2023-07-12 Mosseri Marlio Charles Buy 3,285 15.09 49,570
2023-07-11 Mosseri Marlio Charles Buy 10,000 15.36 153,600
2023-07-07 Mosseri Marlio Charles Buy 8,948 15.19 135,920
2023-07-07 Bentsur Ron (Chairman & CEO) Buy 110 16.19 1,780
2023-07-06 Mosseri Marlio Charles Buy 3,179 15.01 47,716
2023-07-06 Bentsur Ron (Chairman & CEO) Buy 320 14.88 4,761
2023-07-05 Mosseri Marlio Charles Buy 1,176 15.52 18,251
2023-06-26 Mosseri Marlio Charles Buy 16,760 16.46 275,869
2023-06-26 Bentsur Ron (Chairman & CEO) Buy 750 16.50 12,375
2023-06-23 Mosseri Marlio Charles Buy 73,175 17.43 1,275,440
2023-06-22 Mosseri Marlio Charles Buy 6,999 17.73 124,092
2023-06-21 Mosseri Marlio Charles Buy 6,091 17.71 107,871
2023-06-21 Bentsur Ron (Chairman & CEO) Buy 500 17.88 8,940
2023-06-16 Mosseri Marlio Charles Buy 12,700 17.75 225,425
2023-06-15 Mosseri Marlio Charles Buy 32,124 17.62 566,185
2023-06-08 Bentsur Ron (Chairman & CEO) Buy 120 17.53 2,103
2023-06-07 Bentsur Ron (Chairman & CEO) Buy 230 17.41 4,004
2023-05-31 Bentsur Ron (Chairman & CEO) Buy 330 17.28 5,702
2023-05-24 Bentsur Ron (Chairman & CEO) Buy 200 17.49 3,497
2023-05-16 Bentsur Ron (Chairman & CEO) Buy 320 17.02 5,448
2023-03-27 Poradosu Enrique (Chief Science & Business Officer) Buy 500 11.55 5,775
2023-03-23 Bentsur Ron (Chairman & CEO) Buy 230 12.13 2,789
2023-03-21 Shemesh Shay (Chief Dev. & Ops. Officer) Buy 420 11.99 5,035
2023-03-21 Bentsur Ron (Chairman & CEO) Buy 480 12.08 5,798
2023-03-15 Shemesh Shay (Chief Dev. & Ops. Officer) Buy 670 10.71 7,175
2023-03-15 Bentsur Ron (Chairman & CEO) Buy 480 10.91 5,236
2023-03-14 Bentsur Ron (Chairman & CEO) Buy 1,680 10.85 18,228
2022-12-21 Shemesh Shay (Chief Dev. & Ops. Officer) Buy 500 7.65 3,825
2022-11-30 Bentsur Ron (Chairman & CEO) Buy 150 7.45 1,117
2022-11-29 Bentsur Ron (Chairman & CEO) Buy 150 7.45 1,117
2022-11-28 Bentsur Ron (Chairman & CEO) Buy 150 7.40 1,110
2022-11-25 Bentsur Ron (Chairman & CEO) Buy 150 7.38 1,107
2022-11-18 Bentsur Ron (Chairman & CEO) Buy 500 7.23 3,615
2022-11-17 Shemesh Shay (Chief Dev. & Ops. Officer) Buy 150 7.20 1,080
2022-11-17 Bentsur Ron (Chairman & CEO) Buy 250 7.24 1,810
2022-11-16 Shemesh Shay (Chief Dev. & Ops. Officer) Buy 150 7.10 1,065
2022-09-30 Bentsur Ron (Chairman & CEO) Buy 500 7.46 3,730
2022-09-28 Bentsur Ron (Chairman & CEO) Buy 500 7.23 3,615
2022-09-26 Bentsur Ron (Chairman & CEO) Buy 500 7.69 3,845
2022-09-23 Shemesh Shay (Chief Dev. & Ops. Officer) Buy 220 7.87 1,731
2022-09-23 Bentsur Ron (Chairman & CEO) Buy 1,000 7.93 7,930
2022-09-02 Shemesh Shay (Chief Dev. & Ops. Officer) Buy 404 8.31 3,357
2022-09-02 Bentsur Ron (Chairman & CEO) Buy 1,200 8.37 10,043
2022-09-01 Shemesh Shay (Chief Dev. & Ops. Officer) Buy 1,530 8.07 12,347
2022-09-01 Bentsur Ron (Chairman & CEO) Buy 500 8.11 4,054
2022-08-31 Shemesh Shay (Chief Dev. & Ops. Officer) Buy 1,476 8.07 11,911
2022-08-29 Bentsur Ron (Chairman & CEO) Buy 1,000 9.07 9,070
2022-08-23 Bentsur Ron (Chairman & CEO) Buy 500 9.00 4,500
2022-08-19 Bentsur Ron (Chairman & CEO) Buy 5,000 8.99 44,950
2022-08-18 Bentsur Ron (Chairman & CEO) Buy 14,426 8.58 123,775
2022-08-11 Bentsur Ron (Chairman & CEO) Buy 19,669 8.40 165,219
2022-06-29 Bentsur Ron (Chairman & CEO) Buy 3,700 11.62 42,994
2022-06-28 Bentsur Ron (Chairman & CEO) Buy 300 11.82 3,546
2022-06-24 Bentsur Ron (Chairman & CEO) Buy 400 12.18 4,872
2022-06-23 Bentsur Ron (Chairman & CEO) Buy 200 11.40 2,280
2022-06-22 Bentsur Ron (Chairman & CEO) Buy 100 13.10 1,310
2022-05-27 Bentsur Ron (Chairman & CEO) Buy 500 15.74 7,870
2022-05-26 Bentsur Ron (Chairman & CEO) Buy 500 15.90 7,950
2022-05-20 Shemesh Shay (Chief Dev. & Ops. Officer) Buy 300 16.54 4,962
2022-05-20 Bentsur Ron (Chairman & CEO) Buy 1,000 16.28 16,280
2022-05-19 Bentsur Ron (Chairman & CEO) Buy 200 18.95 3,790
2022-05-18 Bentsur Ron (Chairman & CEO) Buy 1,700 19.55 33,226
2022-05-17 Shemesh Shay (Chief Dev. & Ops. Officer) Buy 142 19.55 2,776
2022-05-17 Bentsur Ron (Chairman & CEO) Buy 310 20.30 6,293
2022-05-16 Shemesh Shay (Chief Dev. & Ops. Officer) Buy 100 19.28 1,928
2022-05-16 Bentsur Ron (Chairman & CEO) Buy 1,000 19.32 19,320
2022-05-13 Bentsur Ron (Chairman & CEO) Buy 700 18.10 12,670
2022-05-12 Shemesh Shay (Chief Dev. & Ops. Officer) Buy 1,278 15.68 20,039
2022-05-12 Kaplan Matthew L. Buy 3,000 16.71 50,145
2022-05-12 Hoberman Kenneth Buy 6,000 17.40 104,399
2022-05-12 Bentsur Ron (Chairman & CEO) Buy 12,245 16.09 196,985
2022-03-28 Bentsur Ron (Chairman & CEO) Buy 4,000 7.05 28,200
2022-03-17 Bentsur Ron (Chairman & CEO) Buy 7,000 7.63 53,410
2022-02-14 Bentsur Ron (Chairman & CEO) Buy 8,000 5.88 47,040
2022-02-10 Bentsur Ron (Chairman & CEO) Buy 8,500 6.34 53,890
2022-02-07 Poradosu Enrique (Chief Science & Business Officer) Buy 800 3.88 3,104
2022-02-07 Shemesh Shay (Chief Development Officer) Buy 846 3.47 2,935
2022-02-07 Bentsur Ron (Chairman & CEO) Buy 20,000 6.09 121,800
2022-02-04 Poradosu Enrique (Chief Science & Business Officer) Buy 3,800 3.35 12,730
2022-02-04 Shemesh Shay (Chief Development Officer) Buy 2,100 3.38 7,098
2022-02-04 Bentsur Ron (Chairman & CEO) Buy 212,500 4.45 944,562

Insider trading activities including stock purchases, stock sales, and option exercises of NVCT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Nuvectis Pharma, Inc. (symbol NVCT, CIK number 1875558) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.